ADMA Biologics ADMA Return on invested capital

Return on invested capital at other companies

AbCellera Biologics Inc.ABCL

-23.5%-2.9pp

Lifecore Biomedical, Inc.LFCR

-29.3%—

AnaptysBio, Inc.ANAB

-255.3%-510pp

Absci CorporationABSI

-80.3%+11.1pp

Avalo TherapeuticsAVTX

-42.9%—

AbbVieABBV

17.1%—

FAQ

What is ADMA Biologics's return on invested capital?

ADMA Biologics (ADMA) reported return on invested capital of 44.1% in Q2 2026.

How has ADMA Biologics's return on invested capital changed year-over-year?

ADMA Biologics's return on invested capital decreased by 39.2% year-over-year, from 72.6% to 44.1%.

What is the long-term trend for ADMA Biologics's return on invested capital?

Over 5 years (2020 to 2025), ADMA Biologics's return on invested capital has grown at a -17.2% compound annual growth rate (CAGR), from -99% to 38.6%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.